Work is underway at Queen’s £32m Centre for Experimental Medicine (CEM) with the appointment of O’Hare & McGovern as the main contractor.

At the peak of construction, the Centre will support 400 jobs in the building sector, including O’Hare & McGovern staff and other construction-related jobs. And over 100 new academic posts will be created for scientists and allied professions when CEM opens in 2015.

CEM is being built on Queen’s Institute of Health Sciences campus on Jubilee Road (opposite Belfast City Hospital) where several dedicated,  high quality research centres focused on cancer, infectious disease, public health and population genetics are already based.

The facility will eventually provide accommodation for some 330 members of staff specialising in research into finding cures for eye disease and diabetes, and the development of a global programme to aid understanding of the genetics of complex chronic diseases.

The work of the Centre is a focus of Queen’s ambitious £140m Beyond fundraising campaign which will provide philanthropic funding to support research of global significance and importance. The four storey building will be co-located with the existing Centre for Cancer Research and Cell Biology to encourage joint working and discovery between researchers.

Speaking at the announcement, Gary Jebb, Queen’s Director of Estates, said: “O’Hare & McGovern is one of Northern Ireland’s leading construction firms, and as such, Queen’s is delighted to appoint it as lead contractor for our new Centre for Experimental Medicine. In the last year, the University has invested over £35m in building projects, creating over 700 construction-related jobs in the local economy, and we are proud that today’s announcement reinforces Queen’s continuing commitment to supporting the Northern Ireland economy and especially the local construction sector.”

Eamon O’Hare, Managing Director of O’Hare & McGovern, said: “The construction industry is currently a very difficult sector to be operating in. We are delighted to have been awarded this contract to continue our longstanding relationship with Queen’s. The new centre will offer world class facilities for the University with exceptional design, construction and engineering. This announcement will help to secure jobs and offers an impetus to the local construction industry.”

Professor Patrick Johnston, Dean of the School of Medicine, Dentistry and Biomedical Sciences added: “This new Centre will be a key driver for change in a range of health and biotechnology activities in Northern Ireland and further afield. Today’s announcement that construction is due to begin is good news for everyone in Northern Ireland as we can all look forward to benefitting from improved diagnosis and treatments of debilitating diseases."

Other companies who will be working on the CEM build as part of the design team include: Ostick and Williams, Belfast, and Ashen and Allen, London (Architect and Lead Consultant); WYG, Belfast (Mechanical and Electrical Engineer); Albert Fry Associates, Belfast (Civil and Structural Engineer); Turner and Townsend, Belfast (Quantity Surveyor); Faithful and Gould, Belfast (CDMC Co-ordinator); and Delap and Waller, Antrim (BREEAM Assessor).

The CEM is being funded through a series of grants and philanthropic donations from the UK Research Partnership Investment Fund (UKRPIF), The Atlantic Philanthropies, The Wellcome Trust, The Wolfson Foundation, The Sir Jules Thorn Charitable Trust, Insight Trust for the Visually Impaired and The Queen’s University of Belfast Foundation.

Top of Page